The risk of organ-based comorbidities in psoriasis: a systematic review and meta-analysis.
An Bras Dermatol
; 97(5): 612-623, 2022.
Article
en En
| MEDLINE
| ID: mdl-35850940
BACKGROUND: The close relationship between psoriasis and concomitant diseases is widely accepted. However, a comprehensive analysis of organ-based comorbidities in psoriasis is still lacking. OBJECTIVE: The authors aimed to present the risk of organ-based comorbidities in psoriasis by comparing the general population. METHODS: The authors retrieved a search of Pubmed, EMBASE, and Cochrane databases for studies reporting organ-based comorbidities in psoriasis versus the general population. Observational studies that met the following criteria were assessed: 1) Psoriasis diagnosis; 2) Cardiovascular or kidney or liver or respiratory or cerebrovascular outcomes; 3) Comparison group of individuals without psoriasis. Pooled Relative Risks (pRRs) and 95% Confidence Intervals (CIs) were calculated by using the random-effect model. RESULTS: Fifteen observational studies with 216,348 psoriatic patients and 9,896,962 individuals from the general population were included. Psoriasis showed a greater risk of organ-based comorbidities. Compared to the general population, pRR for all organ-based comorbidities was 1.20 (95% CI 1.11â1.31) in psoriasis, and pRR was lower in mild 0.61 (95% CI 0.46â0.81) than in moderate/severe patients. pRR was 1.20 (95% CI 1.11â1.30) for cardiovascular, 1.56 (95% CI 1.20â2.04), and 1.75 (95% CI 1.33â2.29) for cerebrovascular and liver diseases, respectively. pRR for coexisting renal and cardiovascular events was 1.09 (95% CI 1.01â1.18). pRR for coexisting renal and cerebrovascular events was 1.28 (95% CI 0.99â1.66). pRR for coexisting renal and liver diseases was 1.46 (95% CI 1.10â1.94). pRR for coexisting cardiovascular and liver diseases was 1.41 (95% CI 1.11â1.80). STUDY LIMITATIONS: There is heterogeneity. CONCLUSION: Psoriasis has a higher risk of single and multiple organ-based comorbidities than the general population. The present study will further improve attention to psoriasis as a systemic inflammatory disease.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Psoriasis
/
Hepatopatías
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Revista:
An Bras Dermatol
Año:
2022
Tipo del documento:
Article
Pais de publicación:
España